Temozolomide-modulated glioma proteome: Role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity-Reference-Cited by-同舟云学术

Temozolomide-modulated glioma proteome: Role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity

Published:2013-06-14 Issue:14 Volume:13 Page:2113-2124
ISSN:1615-9853
Container-title:PROTEOMICS
language:en
Short-container-title:Proteomics

Author:

Kumar Durairaj M.¹,Patil Vikas¹,Ramachandran Bini²,Nila Murugesan V.²,Dharmalingam Kuppamuthu²,Somasundaram Kumaravel¹

Affiliation:

1. Department of Microbiology and Cell Biology; Indian Institute of Science; Bangalore India

2. Department of Genetic Engineering; School of Biotechnology, Madurai Kamaraj University; Madurai India

Funder

DBT

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pmic.201200261/fullpdf

Reference49 articles.

1. Malignant astrocytic glioma: genetics, biology, and paths to treatment;Furnari;Genes. Dev.,2007

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol.,2009

3. Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase;Pegg;Prog. Nucleic Acid Res. Mol. Biol.,1995

4. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine;Stevens;Cancer Res.,1987

5. Sensitivity of short-term cultures derived from human malignant glioma to the anti-cancer drug temozolomide;Sankar;Anticancer Drugs,1999

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?;Frontiers in Oncology;2023-04-26

2. Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma;Journal of Healthcare Engineering;2022-03-19

3. Comprehensive Pan-Cancer Analysis of IRAK Family Genes Identifies IRAK1 as a Novel Oncogene in Low-Grade Glioma;Journal of Oncology;2022-02-15

4. Interleukin‑1 receptor‑associated kinase 4 as a potential biomarker: Overexpression predicts poor prognosis in patients with glioma;Oncology Letters;2021-02-03

5. The development and clinical applications of proteomics: an Indian perspective;Expert Review of Proteomics;2020-06-02